For: | Gatselis NK, Tornai T, Shums Z, Zachou K, Saitis A, Gabeta S, Albesa R, Norman GL, Papp M, Dalekos GN. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients. World J Gastroenterol 2020; 26(34): 5130-5145 [PMID: 32982114 DOI: 10.3748/wjg.v26.i34.5130] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v26/i34/5130.htm |
Number | Citing Articles |
1 |
Kunpeng Cao, Liuxi Wu, Xinyue Wang, Hongyan Deng, Ya Yuan, Lu Li, Chaoli Xu, Xinhua Ye. Risk Factors for Early Recurrence After Radical Resection of Hepatocellular Carcinoma Based on Preoperative Contrast-Enhanced Ultrasound and Clinical Features. Technology in Cancer Research & Treatment 2024; 23 doi: 10.1177/15330338241281327
|
2 |
Qi Yan, Yuan-song Sun, Ran An, Fang Liu, Qi Fang, Zhen Wang, Tao Xu, Lijian Chen, Jian Du. Application and progress of the detection technologies in hepatocellular carcinoma. Genes & Diseases 2023; 10(5): 1857 doi: 10.1016/j.gendis.2022.04.003
|
3 |
Yinggang Hua, Jingqing Dong, Jinsong Hong, Bailin Wang, Yong Yan, Zhiming Li. Clinical applications of circulating tumor cells in hepatocellular carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.968591
|
4 |
Antonio Gil-Gómez, Ángela Rojas, Chang-Hai Liu, Rocio Gallego-Duran, Rocio Muñoz-Hernandez, Giorgio Fassina, Patrizia Pontisso, Javier Ampuero, Manuel Romero-Gómez. Combination of squamous cell carcinoma antigen immunocomplex and alpha-fetoprotein in mid- and long-term prediction of hepatocellular carcinoma among cirrhotic patients. World Journal of Gastroenterology 2021; 27(48): 8343-8356 doi: 10.3748/wjg.v27.i48.8343
|
5 |
Huan Zhang, Xuezhong Lei. Research Advance in GP73 in the Clinical Diagnosis and Treatment of Patients with Chronic Hepatitis B. Diseases and Research 2022; 2(2): 53 doi: 10.54457/DR.202202002
|
6 |
Jiazhou Ye, Xing Gao, Xi Huang, Shilin Huang, Dandan Zeng, Wenfeng Luo, Can Zeng, Cheng Lu, Lu Lu, Hongyang Huang, Kaixiang Mo, Julu Huang, Shizhou Li, Minchao Tang, Tianzhun Wu, Rongyun Mai, Min Luo, Mingzhi Xie, Shan Wang, Yongqiang Li, Yan Lin, Rong Liang. Integrating Single-Cell and Spatial Transcriptomics to Uncover and Elucidate GP73-Mediated Pro-Angiogenic Regulatory Networks in Hepatocellular Carcinoma. Research 2024; 7 doi: 10.34133/research.0387
|
7 |
Mingjie Yao, Leijie Wang, Jianwen Wang, Yanna Liu, Shuhong Liu, Jingmin Zhao, Fengmin Lu, Wen-Jun Tu. Diagnostic Value of Serum Golgi Protein 73 for Liver Inflammation in Patients with Autoimmune Hepatitis and Primary Biliary Cholangitis. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/4253566
|
8 |
Jacek Baj, Łukasz Bryliński, Filip Woliński, Michał Granat, Katarzyna Kostelecka, Piotr Duda, Jolanta Flieger, Grzegorz Teresiński, Grzegorz Buszewicz, Marzena Furtak-Niczyporuk, Piero Portincasa. Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know. Cancers 2022; 14(6): 1493 doi: 10.3390/cancers14061493
|
9 |
Endrit Shahini, Giuseppe Pasculli, Antonio Giovanni Solimando, Claudio Tiribelli, Raffaele Cozzolongo, Gianluigi Giannelli. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review. International Journal of Molecular Sciences 2023; 24(5): 4286 doi: 10.3390/ijms24054286
|
10 |
Pranathi Pappu, Urvashi Vijay, Dhatri Madduru, Ngalah Bidii Stephen, Prashanth Suravajhala, Obul Reddy Bandapalli. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 281 doi: 10.1016/B978-0-323-98807-0.00005-3
|
11 |
Julia Maroto-García, Ana Moreno Álvarez, María P. Sanz de Pedro, Antonio Buño-Soto, Álvaro González. Serum biomarkers for liver fibrosis assessment. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2024; 5(2): 115 doi: 10.1515/almed-2023-0081
|
12 |
Chen Hui-ling, Huang Kang-ming, Zhao Yu, Deng Yin-han, Du Huang, Xiao Shu-ping, Chen Hong-bin. The potential value of serum GP73 in the ancillary diagnosis and grading of liver cirrhosis. Scandinavian Journal of Clinical and Laboratory Investigation 2023; 83(2): 95 doi: 10.1080/00365513.2023.2175238
|
13 |
Robin Zenlander, Claudia Fredolini, Jochen M. Schwenk, Ingvar Rydén, Peter Påhlsson, Christian Löwbeer, Gösta Eggertsen, Per Stål. A wide scan of plasma proteins demonstrates thioredoxin reductase 1 as a potential new diagnostic biomarker for hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 2023; 58(9): 998 doi: 10.1080/00365521.2023.2194008
|
14 |
Siyi Feng, Haibin Tu, Lihong Chen. A novel model predicted liver cirrhosis constructed by ultrasound and serological in autoimmune liver hepatitis. Medicine 2023; 102(38): e35295 doi: 10.1097/MD.0000000000035295
|
15 |
Zhiyang Chen, Yichen Ma, Jingyao Cai, Mei Sun, Ling Zeng, Fengxi Wu, Yiru Zhang, Min Hu. Serum biomarkers for liver fibrosis. Clinica Chimica Acta 2022; 537: 16 doi: 10.1016/j.cca.2022.09.022
|
16 |
Rui-Nan Zhang, Jian-Gao Fan. Lipid metabolism-related long noncoding RNAs: A potential prognostic biomarker for hepatocellular carcinoma. World Journal of Gastroenterology 2024; 30(33): 3799-3802 doi: 10.3748/wjg.v30.i33.3799
|
17 |
Philip M. Hemken, Xuzhen Qin, Lori J. Sokoll, Laurel Jackson, Fan Feng, Peng Li, Susan H. Gawel, Bailin Tu, Zhihong Lin, James Hartnett, David Hawksworth, Bryan C. Tieman, Toru Yoshimura, Hideki Kinukawa, Shaohua Ning, Enfu Liu, Fanju Meng, Fei Chen, Juru Miao, Xuan Mi, Xin Tong, Daniel W. Chan, Gerard J. Davis. Validation of the novel GLAS algorithm as an aid in the detection of liver fibrosis and cirrhosis based on GP73, LG2m, age, and sex. Clinical Proteomics 2023; 20(1) doi: 10.1186/s12014-023-09444-7
|
18 |
Meng-Yuan Liu, Lu Huang, Jiang-Feng Wu, Hong-Bing Zhang, Wen-Bing Ai, Rui-Tao Zhang. Possible roles of Golgi protein-73 in liver diseases. Annals of Hepatology 2022; 27(5): 100720 doi: 10.1016/j.aohep.2022.100720
|
19 |
Xu Zhang, Li-Na Wu, Xiao-Qing Li, Xia Luo, Shui-Wei Liu, Le Zhang, Shah Nawaz, Li-Na Ma, Xiang-Chun Ding. Whether the Golgi protein 73 could be a diagnostic serological marker in hepatocellular carcinoma: a meta analysis. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02685-8
|
20 |
George N. Dalekos, Kalliopi Azariadis, Vasiliki Lygoura, Pinelopi Arvaniti, Stella Gampeta, Nikolaos K. Gatselis. Autoimmune hepatitis in patients aged 70 years or older: Disease characteristics, treatment response and outcome. Liver International 2021; 41(7): 1592 doi: 10.1111/liv.14900
|
21 |
Nikolaos K. Gatselis, Kalliopi Zachou, George Giannoulis, Stella Gabeta, Gary L. Norman, George N. Dalekos. Serum Cartilage Oligomeric Matrix Protein and Golgi Protein-73: New Diagnostic and Predictive Tools for Liver Fibrosis and Hepatocellular Cancer?. Cancers 2021; 13(14): 3510 doi: 10.3390/cancers13143510
|
22 |
Marzia Tagliaferro, Mariapaola Marino, Valerio Basile, Krizia Pocino, Gian Ludovico Rapaccini, Gabriele Ciasca, Umberto Basile, Valeria Carnazzo. New Biomarkers in Liver Fibrosis: A Pass through the Quicksand?. Journal of Personalized Medicine 2024; 14(8): 798 doi: 10.3390/jpm14080798
|
23 |
Julia Maroto-García, Ana Moreno-Álvarez, María P. Sanz de Pedro, Antonio Buño-Soto, Álvaro González. Biomarcadores séricos para la evaluación de la fibrosis hepática. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2024; 5(2): 131 doi: 10.1515/almed-2023-0172
|
24 |
Saloni Sinha, Nora Hassan, Robert E. Schwartz. Organelle stress and alterations in interorganelle crosstalk during liver fibrosis. Hepatology 2024; 79(2): 482 doi: 10.1097/HEP.0000000000000012
|
25 |
Jingjing Chen, Yaqi Zhu, Qingcui Wang, Jinya Ding, Xiaohua Chen. Advances in clinical detection methods and nanomaterials for autoimmune liver diseases. Nano TransMed 2023; 2(2-3): 100003 doi: 10.1016/j.ntm.2023.100003
|
26 |
Yujuan Liu, Jiyin Wang, Ruixiang Yang, Yuning Cheng, Yue Zhou, Hui Li, Wei Jiang, Xiaowei Zhang. GP73-mediated secretion of AFP and GP73 promotes proliferation and metastasis of hepatocellular carcinoma cells. Oncogenesis 2021; 10(10) doi: 10.1038/s41389-021-00358-3
|
27 |
Shanghao Liu, Jianzhong Ma, Ping Chen, Shirong Liu, Ying Guo, Mingjie Tan, Xiaoqing Guo, Yinong Feng, Qinghui Wang, Wenhua Li, Chengchen Yang, Bo Gao, Yongli Hua, Ning Liu, Haolin Song, Ruiling He, Ruiying Wang, Qi Gao, Chuan Liu, Xiaolong Qi. Novel serum biomarker of Golgi protein 73 for the diagnosis of clinically significant portal hypertension in patients with compensated cirrhosis. Journal of Medical Virology 2024; 96(1) doi: 10.1002/jmv.29380
|
28 |
Xiaopan Yang, Xiaojing Fan, Jiangyue Feng, Tinghui Fan, Jingfei Li, Linfei Huang, Luming Wan, Huan Yang, Huilong Li, Jing Gong, Yanhong Zhang, Qi Gao, Fei Zheng, Lei Xu, Haotian Lin, Dandan Zhang, Hongbin Song, Yufei Wang, Xueping Ma, Zhiwei Sun, Cheng Cao, Xiaoli Yang, Hui Zhong, Yi Fang, Congwen Wei. GP73 blockade alleviates abnormal glucose homeostasis in diabetic mice. Journal of Molecular Endocrinology 2023; 70(2) doi: 10.1530/JME-22-0103
|
29 |
Ion Mărunţelu, Alexandra-Elena Constantinescu, Razvan-Adrian Covache-Busuioc, Ileana Constantinescu. The Golgi Apparatus: A Key Player in Innate Immunity. International Journal of Molecular Sciences 2024; 25(7): 4120 doi: 10.3390/ijms25074120
|
30 |
Guiyin Li, Bo Wang, Shengnan Li, Xinhao Li, Ruijie Yan, Xiaohong Tan, Jintao Liang, Zhide Zhou. Competitive electrochemical aptasensor for high sensitivity detection of liver cancer marker GP73 based on rGO-Fc-PANi nanocomposites. Bioelectrochemistry 2024; 160: 108767 doi: 10.1016/j.bioelechem.2024.108767
|
31 |
Kohilan Gananandan, Rabiah Singh, Gautam Mehta. Systematic review and meta-analysis of biomarkers predicting decompensation in patients with compensated cirrhosis. BMJ Open Gastroenterology 2024; 11(1): e001430 doi: 10.1136/bmjgast-2024-001430
|